Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

AI mental health chatbots feel empathetic, but safety evidence still lags

27

Jul 2026

AI mental health chatbots feel empathetic, but safety evidence still lags

Immune dysregulation may contribute to depression, schizophrenia, bipolar disorder, and anxiety through chronic inflammation, altered neuroimmune signaling, genetic susceptibility, and stress-related epigenetic changes. Evidence also suggests that biologically defined patient subgroups may benefit from more precise, immune-informed approaches to diagnosis and treatment.

Wild bird surveillance reveals how H5Nx flu keeps returning to China

26

Jul 2026

Wild bird surveillance reveals how H5Nx flu keeps returning to China

Long-term wild bird surveillance across China revealed shifting H5Nx avian influenza patterns, with H5N1, H5N8, and clade 2.3.4.4b viruses changing over time and across migratory flyways. Genomic analyses suggest recent H5Nx detections in China largely reflect repeated reintroductions through migratory birds rather than sustained local circulation.

Study finds widespread nutrition concerns in packaged toddler foods

26

Jul 2026

Study finds widespread nutrition concerns in packaged toddler foods

An audit of toddler foods sold at 21 grocery stores in Texas revealed that 4 out of 5 products were ultra-processed and 49% of all products failed to meet at least one nutrient standard established by the World Health Organization (WHO) Nutrition and Promotion Profile Model (NPPM) for commercial foods intended for children aged 6-36 months.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.